Daily Bulletin

Men's Weekly

.

RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients

Recruitment completed for Part A of the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care

Top-line results for Part A of the study, designed to evaluate safety and tolerability of RHB-107 and dose selection, expected in Q1/ 22

RHB-107 is...

Read more: RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study...

Business News

What Designers Really Think About Your Current Marketing Collateral

Key Takeaways: Designers notice structure, typography, and colour choices before the content itself Consistency across all collateral strengthens brand recognition and builds trust Overly bu...

Daily Bulletin - avatar Daily Bulletin

How to Choose the Right Air Conditioner for Your Home or Business

In Australia’s climate, where summer heat can be intense and winter chills are felt in many regions, air conditioning has become more than just a luxury; it’s an essential part of comfortable living. ...

Daily Bulletin - avatar Daily Bulletin

Why Heavy Duty Moving Dollies Are Essential for Safe Transport in Australia

Moving heavy or bulky items can be challenging, especially when it involves transporting goods across warehouses, offices, or even during residential relocations. In Australia, where industries like c...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals